CNN values your feedback [CNN]
Longeveron Inc. - Class A Common stock (LGVN)
Company Research
Source: CNN
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL. Sector Health Technology Industry Employees Founded Website Key terms LGVN Financials Q earnings, quarter ending Dec 30, 2023 Total revenue 63.00K Net income - 6.03M Earnings per share Net profit margin Free cash flow - 4.16M Debt-to-equity ratio Key terms LGVN Forecasts 2 analyst ratings buy hold sell We're sorry, but this information is temporarily unavailable. LGVN Competitors Key terms
Show less
Read more
Impact Snapshot
Event Time:
LGVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGVN alerts
High impacting Longeveron Inc. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
LGVN
News
- Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 [Yahoo! Finance]Yahoo! Finance
- Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024GlobeNewswire
- Longeveron Inc. (NASDAQ: LGVN) had its price target raised by analysts at HC Wainwright from $6.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- Longeveron to Present at the Planet MicroCap Showcase [Yahoo! Finance]Yahoo! Finance
- Longeveron to Present at the Planet MicroCap ShowcaseGlobeNewswire
LGVN
Earnings
- 11/10/23 - Miss
LGVN
Sec Filings
- 4/30/24 - Form S-1
- 4/25/24 - Form D
- 4/18/24 - Form 8-K
- LGVN's page on the SEC website